New York, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Live Cell Encapsulation Industry" - https://www.reportlinker.com/p06032069/?utm_source=GNW
1 Million in the year 2020, is projected to reach a revised size of US$321.9 Million by 2027, growing at a CAGR of 3.3% over the analysis period 2020-2027. Alginate, one of the segments analyzed in the report, is projected to record a 3.9% CAGR and reach US$96 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Chitosan segment is readjusted to a revised 3.3% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $69.6 Million, While China is Forecast to Grow at 5.3% CAGR
- The Live Cell Encapsulation market in the U.S. is estimated at US$69.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$63.2 Million by the year 2027 trailing a CAGR of 5.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2% and 2.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.
- HEMA-MMA Segment to Record 3% CAGR
- In the global HEMA-MMA segment, USA, Canada, Japan, China and Europe will drive the 2.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$30.8 Million in the year 2020 will reach a projected size of US$37.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$41.4 Million by the year 2027, while Latin America will expand at a 3.2% CAGR through the analysis period.
- Select Competitors (Total 43 Featured) -
- Altucell, Inc.
- Beta-O2 Technologies Ltd
- Biotime, Inc.
- Blacktrace Group
- Büchi Labortechnik AG
- Defymed
- Evonik Industries
- Gloriana Therapeutics
- Kadimastem
- Living Cell Technologies
- Neurotech Holdings, LLC.
- Pharmacyte Biotech, Inc.
- Sernova Corporation
- Sigilon Therapeutics
- Viacyte, Inc.
Read the full report: https://www.reportlinker.com/p06032069/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Live Cell
Encapsulation by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Live Cell Encapsulation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Live Cell Encapsulation
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Alginate by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 5: World Historic Review for Alginate by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 6: World 15-Year Perspective for Alginate by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Chitosan by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Chitosan by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 9: World 15-Year Perspective for Chitosan by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for HEMA-MMA by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 11: World Historic Review for HEMA-MMA by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 12: World 15-Year Perspective for HEMA-MMA by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Siliceous
Encapsulates by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Siliceous Encapsulates by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Siliceous Encapsulates
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Cellulose Sulfate
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 17: World Historic Review for Cellulose Sulfate by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Cellulose Sulfate by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 19: World Current & Future Analysis for PAN-PVC by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 20: World Historic Review for PAN-PVC by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 21: World 15-Year Perspective for PAN-PVC by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 22: World Current & Future Analysis for Other Polymer
Types by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 23: World Historic Review for Other Polymer Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Other Polymer Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 25: World Current & Future Analysis for Cell
Transplantation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 26: World Historic Review for Cell Transplantation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 27: World 15-Year Perspective for Cell Transplantation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 28: World Current & Future Analysis for Probiotics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 29: World Historic Review for Probiotics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 30: World 15-Year Perspective for Probiotics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 31: World Current & Future Analysis for Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 32: World Historic Review for Research by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 33: World 15-Year Perspective for Research by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 34: World Current & Future Analysis for Drug Delivery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 35: World Historic Review for Drug Delivery by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 36: World 15-Year Perspective for Drug Delivery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 37: World Current & Future Analysis for Regenerative
Medicine by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 38: World Historic Review for Regenerative Medicine by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 39: World 15-Year Perspective for Regenerative Medicine
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 40: USA Current & Future Analysis for Live Cell
Encapsulation by Polymer Type - Alginate, Chitosan, HEMA-MMA,
Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC and Other
Polymer Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 41: USA Historic Review for Live Cell Encapsulation by
Polymer Type - Alginate, Chitosan, HEMA-MMA, Siliceous
Encapsulates, Cellulose Sulfate, PAN-PVC and Other Polymer
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 42: USA 15-Year Perspective for Live Cell Encapsulation
by Polymer Type - Percentage Breakdown of Value Sales for
Alginate, Chitosan, HEMA-MMA, Siliceous Encapsulates, Cellulose
Sulfate, PAN-PVC and Other Polymer Types for the Years 2012,
2020 & 2027
Table 43: USA Current & Future Analysis for Live Cell
Encapsulation by Application - Cell Transplantation,
Probiotics, Research, Drug Delivery and Regenerative Medicine -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 44: USA Historic Review for Live Cell Encapsulation by
Application - Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 45: USA 15-Year Perspective for Live Cell Encapsulation
by Application - Percentage Breakdown of Value Sales for Cell
Transplantation, Probiotics, Research, Drug Delivery and
Regenerative Medicine for the Years 2012, 2020 & 2027
CANADA
Table 46: Canada Current & Future Analysis for Live Cell
Encapsulation by Polymer Type - Alginate, Chitosan, HEMA-MMA,
Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC and Other
Polymer Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 47: Canada Historic Review for Live Cell Encapsulation by
Polymer Type - Alginate, Chitosan, HEMA-MMA, Siliceous
Encapsulates, Cellulose Sulfate, PAN-PVC and Other Polymer
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 48: Canada 15-Year Perspective for Live Cell
Encapsulation by Polymer Type - Percentage Breakdown of Value
Sales for Alginate, Chitosan, HEMA-MMA, Siliceous Encapsulates,
Cellulose Sulfate, PAN-PVC and Other Polymer Types for the
Years 2012, 2020 & 2027
Table 49: Canada Current & Future Analysis for Live Cell
Encapsulation by Application - Cell Transplantation,
Probiotics, Research, Drug Delivery and Regenerative Medicine -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 50: Canada Historic Review for Live Cell Encapsulation by
Application - Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 51: Canada 15-Year Perspective for Live Cell
Encapsulation by Application - Percentage Breakdown of Value
Sales for Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine for the Years 2012, 2020 &
2027
JAPAN
Table 52: Japan Current & Future Analysis for Live Cell
Encapsulation by Polymer Type - Alginate, Chitosan, HEMA-MMA,
Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC and Other
Polymer Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 53: Japan Historic Review for Live Cell Encapsulation by
Polymer Type - Alginate, Chitosan, HEMA-MMA, Siliceous
Encapsulates, Cellulose Sulfate, PAN-PVC and Other Polymer
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 54: Japan 15-Year Perspective for Live Cell Encapsulation
by Polymer Type - Percentage Breakdown of Value Sales for
Alginate, Chitosan, HEMA-MMA, Siliceous Encapsulates, Cellulose
Sulfate, PAN-PVC and Other Polymer Types for the Years 2012,
2020 & 2027
Table 55: Japan Current & Future Analysis for Live Cell
Encapsulation by Application - Cell Transplantation,
Probiotics, Research, Drug Delivery and Regenerative Medicine -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 56: Japan Historic Review for Live Cell Encapsulation by
Application - Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 57: Japan 15-Year Perspective for Live Cell Encapsulation
by Application - Percentage Breakdown of Value Sales for Cell
Transplantation, Probiotics, Research, Drug Delivery and
Regenerative Medicine for the Years 2012, 2020 & 2027
CHINA
Table 58: China Current & Future Analysis for Live Cell
Encapsulation by Polymer Type - Alginate, Chitosan, HEMA-MMA,
Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC and Other
Polymer Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 59: China Historic Review for Live Cell Encapsulation by
Polymer Type - Alginate, Chitosan, HEMA-MMA, Siliceous
Encapsulates, Cellulose Sulfate, PAN-PVC and Other Polymer
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 60: China 15-Year Perspective for Live Cell Encapsulation
by Polymer Type - Percentage Breakdown of Value Sales for
Alginate, Chitosan, HEMA-MMA, Siliceous Encapsulates, Cellulose
Sulfate, PAN-PVC and Other Polymer Types for the Years 2012,
2020 & 2027
Table 61: China Current & Future Analysis for Live Cell
Encapsulation by Application - Cell Transplantation,
Probiotics, Research, Drug Delivery and Regenerative Medicine -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 62: China Historic Review for Live Cell Encapsulation by
Application - Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 63: China 15-Year Perspective for Live Cell Encapsulation
by Application - Percentage Breakdown of Value Sales for Cell
Transplantation, Probiotics, Research, Drug Delivery and
Regenerative Medicine for the Years 2012, 2020 & 2027
EUROPE
Table 64: Europe Current & Future Analysis for Live Cell
Encapsulation by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 65: Europe Historic Review for Live Cell Encapsulation by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 66: Europe 15-Year Perspective for Live Cell
Encapsulation by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2020 & 2027
Table 67: Europe Current & Future Analysis for Live Cell
Encapsulation by Polymer Type - Alginate, Chitosan, HEMA-MMA,
Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC and Other
Polymer Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 68: Europe Historic Review for Live Cell Encapsulation by
Polymer Type - Alginate, Chitosan, HEMA-MMA, Siliceous
Encapsulates, Cellulose Sulfate, PAN-PVC and Other Polymer
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 69: Europe 15-Year Perspective for Live Cell
Encapsulation by Polymer Type - Percentage Breakdown of Value
Sales for Alginate, Chitosan, HEMA-MMA, Siliceous Encapsulates,
Cellulose Sulfate, PAN-PVC and Other Polymer Types for the
Years 2012, 2020 & 2027
Table 70: Europe Current & Future Analysis for Live Cell
Encapsulation by Application - Cell Transplantation,
Probiotics, Research, Drug Delivery and Regenerative Medicine -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 71: Europe Historic Review for Live Cell Encapsulation by
Application - Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 72: Europe 15-Year Perspective for Live Cell
Encapsulation by Application - Percentage Breakdown of Value
Sales for Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine for the Years 2012, 2020 &
2027
FRANCE
Table 73: France Current & Future Analysis for Live Cell
Encapsulation by Polymer Type - Alginate, Chitosan, HEMA-MMA,
Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC and Other
Polymer Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 74: France Historic Review for Live Cell Encapsulation by
Polymer Type - Alginate, Chitosan, HEMA-MMA, Siliceous
Encapsulates, Cellulose Sulfate, PAN-PVC and Other Polymer
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 75: France 15-Year Perspective for Live Cell
Encapsulation by Polymer Type - Percentage Breakdown of Value
Sales for Alginate, Chitosan, HEMA-MMA, Siliceous Encapsulates,
Cellulose Sulfate, PAN-PVC and Other Polymer Types for the
Years 2012, 2020 & 2027
Table 76: France Current & Future Analysis for Live Cell
Encapsulation by Application - Cell Transplantation,
Probiotics, Research, Drug Delivery and Regenerative Medicine -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 77: France Historic Review for Live Cell Encapsulation by
Application - Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 78: France 15-Year Perspective for Live Cell
Encapsulation by Application - Percentage Breakdown of Value
Sales for Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine for the Years 2012, 2020 &
2027
GERMANY
Table 79: Germany Current & Future Analysis for Live Cell
Encapsulation by Polymer Type - Alginate, Chitosan, HEMA-MMA,
Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC and Other
Polymer Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 80: Germany Historic Review for Live Cell Encapsulation
by Polymer Type - Alginate, Chitosan, HEMA-MMA, Siliceous
Encapsulates, Cellulose Sulfate, PAN-PVC and Other Polymer
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 81: Germany 15-Year Perspective for Live Cell
Encapsulation by Polymer Type - Percentage Breakdown of Value
Sales for Alginate, Chitosan, HEMA-MMA, Siliceous Encapsulates,
Cellulose Sulfate, PAN-PVC and Other Polymer Types for the
Years 2012, 2020 & 2027
Table 82: Germany Current & Future Analysis for Live Cell
Encapsulation by Application - Cell Transplantation,
Probiotics, Research, Drug Delivery and Regenerative Medicine -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 83: Germany Historic Review for Live Cell Encapsulation
by Application - Cell Transplantation, Probiotics, Research,
Drug Delivery and Regenerative Medicine Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 84: Germany 15-Year Perspective for Live Cell
Encapsulation by Application - Percentage Breakdown of Value
Sales for Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine for the Years 2012, 2020 &
2027
ITALY
Table 85: Italy Current & Future Analysis for Live Cell
Encapsulation by Polymer Type - Alginate, Chitosan, HEMA-MMA,
Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC and Other
Polymer Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 86: Italy Historic Review for Live Cell Encapsulation by
Polymer Type - Alginate, Chitosan, HEMA-MMA, Siliceous
Encapsulates, Cellulose Sulfate, PAN-PVC and Other Polymer
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 87: Italy 15-Year Perspective for Live Cell Encapsulation
by Polymer Type - Percentage Breakdown of Value Sales for
Alginate, Chitosan, HEMA-MMA, Siliceous Encapsulates, Cellulose
Sulfate, PAN-PVC and Other Polymer Types for the Years 2012,
2020 & 2027
Table 88: Italy Current & Future Analysis for Live Cell
Encapsulation by Application - Cell Transplantation,
Probiotics, Research, Drug Delivery and Regenerative Medicine -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 89: Italy Historic Review for Live Cell Encapsulation by
Application - Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 90: Italy 15-Year Perspective for Live Cell Encapsulation
by Application - Percentage Breakdown of Value Sales for Cell
Transplantation, Probiotics, Research, Drug Delivery and
Regenerative Medicine for the Years 2012, 2020 & 2027
UNITED KINGDOM
Table 91: UK Current & Future Analysis for Live Cell
Encapsulation by Polymer Type - Alginate, Chitosan, HEMA-MMA,
Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC and Other
Polymer Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 92: UK Historic Review for Live Cell Encapsulation by
Polymer Type - Alginate, Chitosan, HEMA-MMA, Siliceous
Encapsulates, Cellulose Sulfate, PAN-PVC and Other Polymer
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 93: UK 15-Year Perspective for Live Cell Encapsulation by
Polymer Type - Percentage Breakdown of Value Sales for
Alginate, Chitosan, HEMA-MMA, Siliceous Encapsulates, Cellulose
Sulfate, PAN-PVC and Other Polymer Types for the Years 2012,
2020 & 2027
Table 94: UK Current & Future Analysis for Live Cell
Encapsulation by Application - Cell Transplantation,
Probiotics, Research, Drug Delivery and Regenerative Medicine -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 95: UK Historic Review for Live Cell Encapsulation by
Application - Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 96: UK 15-Year Perspective for Live Cell Encapsulation by
Application - Percentage Breakdown of Value Sales for Cell
Transplantation, Probiotics, Research, Drug Delivery and
Regenerative Medicine for the Years 2012, 2020 & 2027
SPAIN
Table 97: Spain Current & Future Analysis for Live Cell
Encapsulation by Polymer Type - Alginate, Chitosan, HEMA-MMA,
Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC and Other
Polymer Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 98: Spain Historic Review for Live Cell Encapsulation by
Polymer Type - Alginate, Chitosan, HEMA-MMA, Siliceous
Encapsulates, Cellulose Sulfate, PAN-PVC and Other Polymer
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 99: Spain 15-Year Perspective for Live Cell Encapsulation
by Polymer Type - Percentage Breakdown of Value Sales for
Alginate, Chitosan, HEMA-MMA, Siliceous Encapsulates, Cellulose
Sulfate, PAN-PVC and Other Polymer Types for the Years 2012,
2020 & 2027
Table 100: Spain Current & Future Analysis for Live Cell
Encapsulation by Application - Cell Transplantation,
Probiotics, Research, Drug Delivery and Regenerative Medicine -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 101: Spain Historic Review for Live Cell Encapsulation by
Application - Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 102: Spain 15-Year Perspective for Live Cell
Encapsulation by Application - Percentage Breakdown of Value
Sales for Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine for the Years 2012, 2020 &
2027
RUSSIA
Table 103: Russia Current & Future Analysis for Live Cell
Encapsulation by Polymer Type - Alginate, Chitosan, HEMA-MMA,
Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC and Other
Polymer Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 104: Russia Historic Review for Live Cell Encapsulation
by Polymer Type - Alginate, Chitosan, HEMA-MMA, Siliceous
Encapsulates, Cellulose Sulfate, PAN-PVC and Other Polymer
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 105: Russia 15-Year Perspective for Live Cell
Encapsulation by Polymer Type - Percentage Breakdown of Value
Sales for Alginate, Chitosan, HEMA-MMA, Siliceous Encapsulates,
Cellulose Sulfate, PAN-PVC and Other Polymer Types for the
Years 2012, 2020 & 2027
Table 106: Russia Current & Future Analysis for Live Cell
Encapsulation by Application - Cell Transplantation,
Probiotics, Research, Drug Delivery and Regenerative Medicine -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 107: Russia Historic Review for Live Cell Encapsulation
by Application - Cell Transplantation, Probiotics, Research,
Drug Delivery and Regenerative Medicine Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 108: Russia 15-Year Perspective for Live Cell
Encapsulation by Application - Percentage Breakdown of Value
Sales for Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine for the Years 2012, 2020 &
2027
REST OF EUROPE
Table 109: Rest of Europe Current & Future Analysis for Live
Cell Encapsulation by Polymer Type - Alginate, Chitosan,
HEMA-MMA, Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC
and Other Polymer Types - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 110: Rest of Europe Historic Review for Live Cell
Encapsulation by Polymer Type - Alginate, Chitosan, HEMA-MMA,
Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC and Other
Polymer Types Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 111: Rest of Europe 15-Year Perspective for Live Cell
Encapsulation by Polymer Type - Percentage Breakdown of Value
Sales for Alginate, Chitosan, HEMA-MMA, Siliceous Encapsulates,
Cellulose Sulfate, PAN-PVC and Other Polymer Types for the
Years 2012, 2020 & 2027
Table 112: Rest of Europe Current & Future Analysis for Live
Cell Encapsulation by Application - Cell Transplantation,
Probiotics, Research, Drug Delivery and Regenerative Medicine -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 113: Rest of Europe Historic Review for Live Cell
Encapsulation by Application - Cell Transplantation,
Probiotics, Research, Drug Delivery and Regenerative Medicine
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 114: Rest of Europe 15-Year Perspective for Live Cell
Encapsulation by Application - Percentage Breakdown of Value
Sales for Cell Transplantation, Probiotics, Research, Drug
Delivery and Regenerative Medicine for the Years 2012, 2020 &
2027
ASIA-PACIFIC
Table 115: Asia-Pacific Current & Future Analysis for Live Cell
Encapsulation by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 116: Asia-Pacific Historic Review for Live Cell
Encapsulation by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 117: Asia-Pacific 15-Year Perspective for Live Cell
Encapsulation by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027
Table 118: Asia-Pacific Current & Future Analysis for Live Cell
Encapsulation by Polymer Type - Alginate, Chitosan, HEMA-MMA,
Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC and Other
Polymer Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032069/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
